REG - Focusrite PLC - Share issuance to Employee Benefit Trust

FocusriteAnnouncement

07/12/2022 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221207:nRSG9271Ia&default-theme=true

RNS Number : 9271I  Focusrite PLC  07 December 2022

Focusrite plc

("Focusrite", the "Company" or "Group")

Share issuance to Employee Benefit Trust

Focusrite plc (AIM: TUNE), the global music and audio products company
supplying hardware and software used by professional and amateur musicians and
the entertainment industry, gives the following update on a share issuance of
new ordinary shares ("New Ordinary Shares") of 0.1 pence each directly to the
Company's Employee Benefit Trust ("EBT").

The Company intends to issue 550,000 New Ordinary Shares at their par value to
the EBT. The New Ordinary Shares are intended to be used by the EBT to satisfy
employee options vesting in future years.

Accordingly, the Company will allot 550,000 New Ordinary Shares to the EBT and
such shares will rank pari passu in all respects with the existing ordinary
shares of the Company. An application has been made for 550,000 New Ordinary
Shares of 0.1 pence each in the capital of the Company to be allotted and
admitted to trading on AIM on or around 9 December 2022 ("Admission").

Following Admission, the Company's issued share capital will comprise
59,211,639 Ordinary Shares, of which 812,042 Ordinary Shares will be held by
the EBT. The Company does not hold any shares in treasury.

- Ends-

 

Enquiries:

 

For further information contact:

 Focusrite plc                                           +44 (0) 149 446 2246
 Tim Carroll, Chief Executive Officer
 Sally McKone, Chief Financial Officer

 Investec Bank plc (Nominated Adviser and Joint Broker)  +44 (0) 20 7597 5970
 David Flin
 William Brinkley
 Charlotte Young

 Peel Hunt LLP (Joint Broker)                            +44 (0) 20 3597 8514
 Paul Gillam
 Michael Burke
 James Smith

 Belvedere Communications                                +44 (0) 20 3008 6864
 John West
 Llew Angus

 

 

Notes to Editors

 

Focusrite plc is a global audio products group that develops and markets
proprietary hardware and software products. Used by audio professionals and
musicians, its solutions facilitate the high-quality production of recorded
and live sound. The Focusrite Group trades under nine established brands:
Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal
Audio, Sequential and Linea.

 

With a high-quality reputation and a rich heritage spanning decades, its
brands are category leaders in the music-making and audio recording
industries. Focusrite and Focusrite Pro offer audio interfaces and other
products for recording musicians, producers and professional audio facilities.
Novation and Ampify products are used in the creation of electronic music,
from synthesisers and grooveboxes to industry-shaping controllers and
inspirational music-making apps. ADAM Audio studio monitors have earned a
worldwide reputation based on technological innovation in the field of studio
loudspeaker technology.  Martin Audio designs and manufactures
performance-ready systems across the spectrum of sound reinforcement
applications. Sequential designs and manufactures high end analogue
synthesizers.  Linea Research designs, develops, manufactures and sells
market innovative professional audio equipment globally.

 

The Focusrite Group has offices in four continents and a global customer base
with a distribution network covering approximately 240 territories.

 

Focusrite plc is traded on the AIM market, London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURFSFFFWEESEFE